BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Abliva - ECPv6.15.14//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Abliva
X-ORIGINAL-URL:https://abliva.com
X-WR-CALDESC:Events for Abliva
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20231025
DTEND;VALUE=DATE:20231027
DTSTAMP:20260403T233536
CREATED:20230920T154429Z
LAST-MODIFIED:20231002T074632Z
UID:3898-1698192000-1698364799@abliva.com
SUMMARY:BioStock Life Science Summit 2023
DESCRIPTION:In late October\, Abliva will attend the BioStock’s Life Science Summit at Medicon Village in Lund. \nMagnus Hansson\, Abliva’s Chief Medical Officer\, will be presenting the company at 09:05 a.m. CET on October 25. \nSee more details and the link to the event below.
URL:https://abliva.com/event/biostock-life-science-summit-2023/
LOCATION:Medicon Village\, Scheeletorget 1\, Lund\, Sweden
CATEGORIES:Investor event
ATTACH;FMTTYPE=image/jpeg:https://abliva.com/wp-content/uploads/2023/09/Medicon_Village.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20231025
DTEND;VALUE=DATE:20231027
DTSTAMP:20260403T233536
CREATED:20231023T142533Z
LAST-MODIFIED:20231023T142533Z
UID:4009-1698192000-1698364799@abliva.com
SUMMARY:Hadean Venture's Annual Event
DESCRIPTION:In October\, Abliva’s CEO\, Ellen Donnelly\, will attend Hadean Venture’s annual event in Oslo.
URL:https://abliva.com/event/hadean-ventures-annual-event/
LOCATION:Oslo\, Norway
CATEGORIES:Investor event
ATTACH;FMTTYPE=image/jpeg:https://abliva.com/wp-content/uploads/2022/09/oslo.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20231113
DTEND;VALUE=DATE:20231117
DTSTAMP:20260403T233536
CREATED:20231002T122633Z
LAST-MODIFIED:20231109T154101Z
UID:3960-1699833600-1700179199@abliva.com
SUMMARY:LSX Inv€$tival Showcase and Jefferies London Healthcare Conference
DESCRIPTION:This fall\, Abliva’s CEO\, Ellen Donnelly will attend the two connected events LSX Inv€$tival Showcase and Jefferies London Healthcare Conference. \nOn November 13 at 11:45 a.m.\, the Abliva’s CEO\, Ellen Donnelly\, will present the company at LSX Inv€$tival Showcase. \nSee the link below for more details.
URL:https://abliva.com/event/lsx-invetival-showcase-and-jefferies-london-healthcare-conference/
LOCATION:London\, London
CATEGORIES:Investor event
ATTACH;FMTTYPE=image/jpeg:https://abliva.com/wp-content/uploads/2022/09/london_big_ben.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20231129
DTEND;VALUE=DATE:20231201
DTSTAMP:20260403T233536
CREATED:20231002T131556Z
LAST-MODIFIED:20231123T082109Z
UID:3968-1701216000-1701388799@abliva.com
SUMMARY:Nordic Life Science Days
DESCRIPTION:In late November\, Abliva will attend Nordic Life Science Days\, at Bella Center in Copenhagen\, Denmark. \nCEO Ellen Donnelly will be presenting the company during the session Biotechnology – Therapeutics & Diagnostics on November 29 at 2:12 p.m. CET in Auditorium 10. \nFollow the link below for more details.
URL:https://abliva.com/event/nordic-life-science-days/
LOCATION:Bella Center\, Center Boulevard 9\, Copenhagen\, 2300\, Denmark
CATEGORIES:BD event,Investor event
ATTACH;FMTTYPE=image/jpeg:https://abliva.com/wp-content/uploads/2023/10/Copenhagen_Nyhavn.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240108
DTEND;VALUE=DATE:20240112
DTSTAMP:20260403T233536
CREATED:20231218T090034Z
LAST-MODIFIED:20231218T091334Z
UID:4095-1704672000-1705017599@abliva.com
SUMMARY:J.P. Morgan Healthcare Conference
DESCRIPTION:In early January 2024\, Abliva’s CEO\, Ellen Donnelly\, will attend the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco\, USA. \nThe conference is a healthcare investment symposium that connects global industry leaders\, emerging fast-growth companies\, innovative technology creators\, and members of the investment community. \nFollow the link below to learn more.
URL:https://abliva.com/event/j-p-morgan-healthcare-conference/
LOCATION:San Francisco\, San Francisco\, United States
CATEGORIES:Investor event
ATTACH;FMTTYPE=image/jpeg:https://abliva.com/wp-content/uploads/2023/12/San_Francisco.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240318
DTEND;VALUE=DATE:20240321
DTSTAMP:20260403T233536
CREATED:20240122T100207Z
LAST-MODIFIED:20240318T085921Z
UID:4130-1710720000-1710979199@abliva.com
SUMMARY:Mitochondrial Medicine - Therapeutic Development
DESCRIPTION:In mid-March\, Abliva will attend the 8th edition of Mitochondrial Medicine – Therapeutic Development in Hinxton\, UK. \nThis annual scientific meeting is focused on mitochondrial disorders and the search for novel effective therapies. \nAbliva’s CMO\, Maguns Hansson\, will join the panel discussion Challenges and opportunities in clinical trials: perspectives\nfrom pharma and funders\, where representatives from other companies in the field as well as academic and clinical experts also participate. \nFollow the link below to learn more.
URL:https://abliva.com/event/mitochondrial-medicine-therapeutic-development-5/
LOCATION:MA
CATEGORIES:Scientific event
ATTACH;FMTTYPE=image/jpeg:https://abliva.com/wp-content/uploads/2024/01/Magnus_Fia_kameraa-e1710752165285.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240416
DTEND;VALUE=DATE:20240418
DTSTAMP:20260403T233536
CREATED:20240130T140102Z
LAST-MODIFIED:20240402T132650Z
UID:4149-1713225600-1713398399@abliva.com
SUMMARY:Kempen Life Sciences Conference
DESCRIPTION:In mid-April\, Abliva will participate at Kempen Life Sciences Conference in Amsterdam\, The Netherlands. \nFor more information\, please click the link below.
URL:https://abliva.com/event/kempen-life-sciences-conference/
LOCATION:MA
CATEGORIES:BD event,Investor event
ATTACH;FMTTYPE=image/jpeg:https://abliva.com/wp-content/uploads/2023/03/Amsterdam.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240512
DTEND;VALUE=DATE:20240515
DTSTAMP:20260403T233536
CREATED:20240122T101953Z
LAST-MODIFIED:20240513T082027Z
UID:4137-1715472000-1715731199@abliva.com
SUMMARY:Bio€quity Europe
DESCRIPTION:In mid-May\, Abliva will travel to the Bio€quity Europe meeting in San Sebastán\, Spain. \n“For more than 20 years\, Bio€quity Europe has been where CEOs and investors gather to network\, partner\, and debate critical issues facing the biotech industry.” \nAbliva’s CEO\, Ellen Donnelly\, will\, together with the company’s CMO\, Magnus Hansson\, be networking and presenting the company during the event. \nFollow the link below to learn more.
URL:https://abliva.com/event/bioequity-europe/
LOCATION:Kursaal Elkargunea Center\, Zurriola Hiribidea\, 1\, San Sebastián\, 20002\, Spain
CATEGORIES:BD event,Investor event
ATTACH;FMTTYPE=image/jpeg:https://abliva.com/wp-content/uploads/2024/01/san_sebastian.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20240521T160000
DTEND;TZID=Europe/Stockholm:20240521T170000
DTSTAMP:20260403T233536
CREATED:20240502T152505Z
LAST-MODIFIED:20240502T152505Z
UID:5203-1716307200-1716310800@abliva.com
SUMMARY:Virtual KOL event on KL1333
DESCRIPTION:Join Abliva for a virtual KOL event featuring Amel Karaa\, MD (Massachusetts General Hospital)\, who will discuss the unmet medical need and current treatment landscape for patients with primary mitochondrial disease. There are currently no approved medicines for the systemic disease. \nThe event will focus on Abliva’s lead program\, KL1333\, which has shown clinically meaningful\, early signals of efficacy in mitochondrial disease patients. This novel therapeutic approach modulates the underlying pathophysiology in mitochondrial disease. KL1333 is currently being evaluated in the pivotal Phase 2 FALCON trial\, with interim analysis expected mid-year 2024. KL1333 has Orphan Drug Designation (ODD) in both Europe and the U.S. and Fast Track designation in the U.S. \nRegistration information \nRegister here: https://lifescievents.com/event/abliva/\nA live question and answer session will follow the formal presentation. Ask your question to: questions@lifesciadvisors.com. \nYou are required to register in advance for the webcast. For those who are unable to attend live\, a replay will be available via the link below.
URL:https://abliva.com/event/virtual-kol-event-on-kl1333/
LOCATION:MA
CATEGORIES:Investor event,Scientific event
ATTACH;FMTTYPE=image/png:https://abliva.com/wp-content/uploads/2024/05/Abliva-Social-Media-v2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240603
DTEND;VALUE=DATE:20240607
DTSTAMP:20260403T233536
CREATED:20240403T115329Z
LAST-MODIFIED:20240604T063745Z
UID:5105-1717372800-1717718399@abliva.com
SUMMARY:BIO International
DESCRIPTION:In early June\, Abliva’s CEO\, Ellen Donnelly\, travels to San Diego to attend BIO International 2024. \nFollow the link below for more information.
URL:https://abliva.com/event/bio-international/
LOCATION:San Diego\, San Diego\, CA\, United States
CATEGORIES:BD event
ATTACH;FMTTYPE=image/png:https://abliva.com/wp-content/uploads/2024/04/BIOInternational_2024.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240626
DTEND;VALUE=DATE:20240630
DTSTAMP:20260403T233536
CREATED:20240402T134632Z
LAST-MODIFIED:20240402T134721Z
UID:5090-1719360000-1719705599@abliva.com
SUMMARY:Mito Med 2024
DESCRIPTION:In late June\, Abliva will attend the US patient organization UMDF’s Mitochondrial Medicine Conference in Cleveland\, Ohio. \n“Each year\, UMDF’s Mitochondrial Medicine Conference brings together the best minds in mitochondrial medicine and the patients we serve. With over 700 attendees representing almost every state in the U.S. and more than 15 different countries\, the Conference is recognized as the world’s preeminent event for mitochondrial disease.” \nClick the link below for more information.
URL:https://abliva.com/event/mito-med-2024/
LOCATION:Cleveland\, Ohio\, Cleveland\, OH\, United States
CATEGORIES:Scientific event
ATTACH;FMTTYPE=image/jpeg:https://abliva.com/wp-content/uploads/2024/04/cleveland.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240918
DTEND;VALUE=DATE:20240920
DTSTAMP:20260403T233536
CREATED:20240613T145109Z
LAST-MODIFIED:20240829T103736Z
UID:5306-1726617600-1726790399@abliva.com
SUMMARY:Nordic Life Science Days
DESCRIPTION:In September\, Abliva will attend the Nordic Life Science Days (NLS days) in Malmö\, Sweden. \nAblia’s CEO\, Ellen Donnelly\, will be presenting the company at 11:00 a.m. CET on September 18\, in the session Biotechnology. \nFollow the link below for more information.
URL:https://abliva.com/event/nordic-life-science-days-2/
LOCATION:Malmömässan\, Mässgatan 6\, Malmö\, 215 32\, Sweden
CATEGORIES:BD event,Scientific event
ATTACH;FMTTYPE=image/jpeg:https://abliva.com/wp-content/uploads/2021/10/malmo.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241025
DTEND;VALUE=DATE:20241028
DTSTAMP:20260403T233536
CREATED:20240829T083852Z
LAST-MODIFIED:20241015T151503Z
UID:5387-1729814400-1730073599@abliva.com
SUMMARY:Mitocon's Mitochondrial Disease Conference
DESCRIPTION:In late October\, Abliva will attend the 14th Mitochondrial Disease Conference\, this year in Padua (IT)\, organized by the Italian patient organization Mitocon. \nAbliva’s CMO\, Magnus Hansson will attend the session: Roundtable with Pharmaceutical Industries and Regulatory Authorities. \nRead more by following the link below.
URL:https://abliva.com/event/mitocons-mitochondrial-disease-conference/
LOCATION:BW Plus Hotel Galileo\, Via Venezia 30\, Padova\, Italy
CATEGORIES:Scientific event
ATTACH;FMTTYPE=image/jpeg:https://abliva.com/wp-content/uploads/2024/08/Padova_It.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241104
DTEND;VALUE=DATE:20241107
DTSTAMP:20260403T233536
CREATED:20240925T065754Z
LAST-MODIFIED:20241104T131804Z
UID:5479-1730678400-1730937599@abliva.com
SUMMARY:BIO-Europe
DESCRIPTION:In early November\, Abliva’s CEO\, Ellen Donnelly\, will attend the BIO-Europe meeting in Stockholm\, Sweden. \nOn Monday\, November 4\, Ellen will be presenting the company at 4:30 p.m. CET. \nFollow the link below for further details.
URL:https://abliva.com/event/bio-europe/
LOCATION:Stockholm\, Stockholm\, Sweden
CATEGORIES:BD event,Investor event
ATTACH;FMTTYPE=image/jpeg:https://abliva.com/wp-content/uploads/2020/10/iStock-578105944_-Sthlm.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241110
DTEND;VALUE=DATE:20241114
DTSTAMP:20260403T233536
CREATED:20241023T094000Z
LAST-MODIFIED:20241104T133548Z
UID:5543-1731196800-1731542399@abliva.com
SUMMARY:CNS Summit 2024
DESCRIPTION:Abliva will attend the CNS Summit 2024\, taking place November 10-13 at Encore Boston Harbor. \nThe company’s CEO\, Ellen Donnelly\, has organized and will join the spotlight panel discussion: Medicines for Mito: Developing Medicines for Mitochondrial Dysfunction Spotlight Session\, on November 11\, at 1:00 p.m. ET\, featuring representatives from Stealth-\, Tisento- and Saol Therapeutics. \nFollow the link below for further details.
URL:https://abliva.com/event/5543/
LOCATION:Encore Boston Harbor\, Boston\, MA\, United States
ATTACH;FMTTYPE=image/png:https://abliva.com/wp-content/uploads/2024/10/Medicines-for-Mito.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241118
DTEND;VALUE=DATE:20241119
DTSTAMP:20260403T233536
CREATED:20241009T130127Z
LAST-MODIFIED:20241104T132226Z
UID:5512-1731888000-1731974399@abliva.com
SUMMARY:Investival Showcase
DESCRIPTION:In mid-November\, Abliva will attend LSX’s Investival Showcase in London\, UK. \nAbliva’s CEO\, Ellen Donnelly\, will be presenting the company at 11:30 a.m. GMT. \nThe Investival Showcase is a Biotech\, Healthtech\, and Medtech Networking & Pitching Event. \nFollow the link below for more details.
URL:https://abliva.com/event/investival-showcase/
LOCATION:Tobacco Dock\, Wapping Lane\, London\, E1W 2SF\, United Kingdom
ATTACH;FMTTYPE=image/jpeg:https://abliva.com/wp-content/uploads/2022/09/london_big_ben.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241119
DTEND;VALUE=DATE:20241122
DTSTAMP:20260403T233536
CREATED:20241009T075456Z
LAST-MODIFIED:20241009T075456Z
UID:5499-1731974400-1732233599@abliva.com
SUMMARY:BioStock Life Science Summit
DESCRIPTION:In late November\, Abliva will participate in BioStock’s Life Science Summit in Lund\, Sweden. \nCMO\, Magnus Hansson\, will be presenting the company at 15:10 CET on November 21. \nFor more details on the event\, follow the link below.
URL:https://abliva.com/event/biostock-life-science-summit-5/
LOCATION:Medicon Village\, Scheeletorget 1\, Lund\, Sweden
ATTACH;FMTTYPE=image/jpeg:https://abliva.com/wp-content/uploads/2022/06/lund_university.jpeg
END:VEVENT
END:VCALENDAR